Results: 16

Syringocystadenoma papilliferum combined with a tubular apocrine adenoma

An. bras. dermatol; 92 (5), 2017
Abstract: Syringocystadenoma papilliferum and tubular apocrine adenoma are rare benign sweat gland tumors. Syringocystadenoma papilliferum occurs alone or in association with other tumors. Although it is rare, the association of tubular apocrine adenoma with syringocystadenoma papilliferum developing in ...

Tumor Phyllodes con transformación a osteosarcoma

Rev. méd. Chile; 145 (8), 2017
Phyllodes tumors account for less than 1% of tumors of the mammary gland, have both epithelial and stromal components and are classified as benign, borderline and malignant. The malignant tumors are highly heterogeneous: they can differentiate to liposarcomas, fibrosarcomas, rhabdomyosarcomas, chondrosar...

Cancer sincronico de endometrio y trompa
Synchronous primary endometrial and tube fallopian cancers

Los tumores sincrónicos del tracto genital femenino son un entidad infrecuente que plantea un reto en el diagnóstico diferencial con la enfermedad metastásica. La mayoría de ellos son cánceres de endometrio y ovario, siendo los tumores sincrónicos de endometrio (CE) y trompa (CT) una asociación ex...

Synchronous anal melanoma and colon adenocarcinoma: case report and review of diagnosis and management

ABCD (São Paulo, Impr.); 29 (4), 2016

The largest western experience with hepatopancreatoduodenectomy: lessons learned with 35 cases

ABCD (São Paulo, Impr.); 29 (1), 2016
Background : Hepatopancreatoduodenectomy is one of the most complex abdominal operations mainly indicated in advanced biliary carcinoma. Aim : To present 10-year experience performing this operation in advanced malignant tumors. Methods : This is a retrospective descriptive study. From 2004 to 2014, 35...

Tumor híbrido parotídeo

Los tumores de glándulas salivales representan el 3%-10% de las neoplasias de cabeza y cuello. La localización más común es en la glándula parótida, representando el 50%-85% de los casos, siendo 20%-30% de ellos malignos. Los siguientes son indicadores de malignidad: Crecimiento acelerado, masa dol...